January 7, 2011

Pfizer has paid Seattle Genetics $8 million to license its antibody technology, Seattle Genetics said Thursday.

January 7, 2011

State health authorities in Colorado are promoting immunization to parents through a broad media campaign.

January 4, 2011

Pfizer will pay Danish biotech company Santaris Pharma $14 million for access to its development platform for RNA-based therapies, Pfizer said Tuesday.

January 3, 2011

This past year saw a lower-than-usual number of new drugs approved by the Food and Drug Administration, due in part to delays at the agency, according to published reports.

December 20, 2010

Drugs for bacterial infections and cancer, and one that could help shape regulations for biosimilars, are featured in the Food and Drug Administration’s annual "Generic Drug Roundup."

December 17, 2010

Frank Baldino, the founder, chairman and CEO of Cephalon, has died, the company said.

December 7, 2010

Drug makers Momenta Pharmaceuticals and Sandoz have filed a lawsuit against Teva Pharmaceutical Industries in the U.S. District Court for the District of Massachusetts, alleging infringement of two patents related to a generic blood-thinning drug.

November 14, 2010

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...

November 9, 2010

Watson Pharmaceuticals biotech subsidiary Eden Biodesign has signed a manufacturing agreement with Dutch biotech company...

November 9, 2010

To express it in modern parlance, follow-on biologics will be a hot mess....

November 2, 2010

The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of...

November 1, 2010

Amgen's SVP research and development, Joe Miletich, urged members of a Food and Drug Administration...

November 1, 2010

The Food and Drug Administration should ensure patient access, safety and efficacy; create a transparent...

October 10, 2010

Johnson & Johnson is set to buy the remaining portion of Dutch biotech company Crucell...

October 6, 2010

Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when...

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 28, 2010

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...

September 27, 2010

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 26, 2010

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 26, 2010

The generics subsidiary of Pfizer is launching a new business focused on authorized generics. Greenstone...

September 26, 2010

Many generic drug companies have long marketed branded drugs on the side, but lately, some...

September 26, 2010

For all its successes, the generic drug industry has had a lot to worry about...